Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» In a Rare Move, FDA Initiates Procedures to Suspend Approval of an ANDA
In a Rare Move, FDA Initiates Procedures to Suspend Approval of an ANDA
In a Rare Move, FDA Initiates Procedures to Suspend Approval of an ANDA
Submitted by
admin
on December 4, 2015 - 8:21pm
Source:
FDA Law Blog
News Tags:
FDA
ANDAs
Armenpharm
Headline:
In a Rare Move, FDA Initiates Procedures to Suspend Approval of an ANDA
Do Not Allow Advertisers to Use My Personal information
